Skip to content

Clinical trials

Recruiting Cardiomyopathy, Hypertrophic trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Hypertrophic Status: Recruiting Country / region: Italy Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20181
20211
20232
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
IRCCS Azienda Ospedaliero-Universitaria di Bologna2
Centro Medico Teknon1
Fatebenefratelli Hospital1
Imbria Pharmaceuticals, Inc.1
Rocket Pharmaceuticals Inc.1
Scientific Institute San Raffaele1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Hypertrophic7
Cardiomyopathy, Dilated3
Fabry Disease3
Amyloid Neuropathies, Familial2
Cardiomyopathies2
Death, Sudden, Cardiac2
Heart Failure2
Arrhythmogenic Right Ventricular Dysplasia1
Cardiomyopathy, Restrictive1
Coronary Artery Disease1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.